Author:
Tonin Fernanda S.,Fernandez-Llimos Fernando,Alves da Costa Filipa
Publisher
Springer International Publishing
Reference81 articles.
1. Agley J, Meyerson BE, Eldridge LA, Crosby RA, Bentele KG, Jun M, et al. Exploration of pharmacist comfort with harm reduction behaviors: cross-sectional latent class analysis. J Am Pharm Assoc. (2003. 2021;62(2):432–40.
2. Ali F, Russell C, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: a national qualitative assessment in Canada. Int J Drug Policy. 2021;93:103237.
3. Ansari B, Tote KM, Rosenberg ES, Martin EG. A rapid review of the impact of systems-level policies and interventions on population-level outcomes related to the opioid epidemic, United States and Canada, 2014–2018. Public Health Rep. 2020;135(1_suppl):100S–27S.
4. Antoniou T, Martins D, Campbell T, Tadrous M, Munro C, Leece P, et al. Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population-based time-series analysis. Addiction. 2021;116(6):1514–20.
5. Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(1):235–48.